This is a service of EIN News a digital news provider
Pharmaceutical Industry Today
Sign up for a free trial
Register Now
Member center Log In
Actos News is an EIN News Service for pharmaceuticals professionals. Constantly updated news and information about pharmaceuticals.
FORMATS: RSS | EMAIL

Latest Actos News

Sort by: relevance (24 hours) relevance date
  • Diabetes Drugs Go Head-to-Head in Study 4 Dec 2009 00:19 GMT
    ... 3 (HealthDay News) -- A class of drugs still taken by millions of people with ... dying and heart failure than the newer treatment metformin, researchers say. Sulfonylureas, long a mainstay ... , also found that the diabetes medications Actos (pioglitazone) and Avandia (rosiglitazone) did not seem ...

  • Diabetes Drugs Go Head-to-Head in Study 4 Dec 2009 01:18 GMT
    ... ) -- A class of drugs still taken by millions of people with ... dying and heart failure than the newer treatment metformin, researchers say. Sulfonylureas, long a mainstay ... , also found that the diabetes medications Actos (pioglitazone) and Avandia (rosiglitazone) did not seem ...

  • Japan`s largest drug maker Takeda plans India foray 2 Dec 2009 14:39 GMT
    ... New Delhi: Japan's largest drug maker Takeda Pharmaceuticals is looking to enter India for which ... Besides, Takeda's best selling anti-diabetic anti-diabetic medicine Actos will lose patent protection in 2011. PTI ...

  • Sulfonylureas Linked To Higher Risk Of Heart Problems 4 Dec 2009 18:11 GMT
    ... Of Heart Problems , a class of drugs long used in the treatment of type 2 diabetes, have been linked ... Beach Post. The study found diabetes drugs Actos (generic: pioglitazone) and Avandia (generic: rosiglitazone) did ...

  • Sulfonylureas Linked to Higher Risks of Death and Heart Failure 4 Dec 2009 02:42 GMT
    ... of Imperial College London, and colleagues. Second-generation drugs in that class were associated with an ... Federation that favor metformin as the initial treatment for type 2 diabetes," the researchers wrote. ... Neither of the thiazolidinediones examined -- pioglitazone (Actos) and rosiglitazone (Avandia) -- were associated with ...

  • Sulfonylureas for diabetes increase risk of heart disease and death, study finds 4 Dec 2009 18:45 GMT
    ... Sulfonylureas, the first family of oral drugs used for treating type 2 diabetes, increase ... the website of BMJ, formerly the British Medical Journal. The good news from the study ... the second-generation drugs. The (Avandia) and pioglitazone (Actos) were not associated with an increased risk ...

  • Takeda looks to India to grow sales 3 Dec 2009 11:32 GMT
    ... to enter the Indian market as it faces patent expiry of its biggest selling drug Actos (pioglitazone) early next year. In November, the company revealed it hopes to snap up ...


1 - 15 / 68      NEXT >>>

Powered by Newsfeed Maker
NOT SATISFIED WITH THIS ACTOS NEWS SECTION? MAKE YOUR OWN WITH THE INBOX ROBOT OR TRY OUR OTHER MEDIA MONITORING SERVICES.
These stories are not published by IPD Group, Inc. and these links will take you to other websites. Some of these websites require their own registration to read their stories.
<<< Please read the disclaimer for more details.>>>
 
 

Take This Poll

For which of the following topics do you have the biggest problem finding news on the Internet? (Nov. 27, 2009)














 

BUSINESS PROMOTION SERVICES

EIN Advertising · Place banner ads on EIN News industry specific publications.

EIN Presswire · Upload press releases to the EIN network and have them submitted to leading journalists and decision-makers worldwide.

EIN Global Events · Reach industry-specific readers and promote events, conferences or exhibitions.

EIN Business Directory · Present company or service information on highly-visible, industry and geo-specific news pages.

NEWS SERVICES

News Publications · In-depth geopolitical and industry specific news coverage aggregated from 35,000 online outlets. Updated every 15 minutes.

News Alerts · Receive a free selection of the day's top stories hand picked by EIN News editors.

Newsfeed Maker · Integrate customized newsfeeds in any format covering all industry and geopolitical topics, updated every 15 minutes.

EIN Presswire · Upload press releases to the EIN network and have them submitted journalists and decision-makers worldwide.

Inbox Robot · Customized newsletters delivered by e-mail. Search a news index monitoring thousands of trusted media sources.

COMPANY BACKGROUND

About EIN News · Established in 1995, EIN News began by supplying business professionals and individuals with relevant and interesting news products. It has grown to become the largest digital news provider in Europe.

Member List · See the partial member list and join a community of professionals from private industry, institutions, and governments that rely on EIN as a critical source for research, breaking news and media services.